| [1] |
CAO Qian, ZHOU Meng, ZHANG Zhen, ZHU Ji.
Prediction risk of radiation proctitis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer using CT radiomics
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 568-575.
|
| [2] |
GAO Yanhong, YU Miao, DONG Lifeng, DAI Miaoke, LI Jun.
Efficacy of a high-risk factor quantitative questionnaire and immune fecal occult blood test in colorectal cancer screening
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 576-581.
|
| [3] |
LIN Ziyi, JIANG Yanji, LIN Qiuling, WEI Xiaoxia, ZHOU Zihan, MA Yingying, LIN Biaoyang, YU Hongping, LIANG Xiumei.
Auxiliary diagnostic value of serum chitinase-3-like protein 1 levels in hepatitis B virus-related hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 582-589.
|
| [4] |
CHEN Mengmeng, CHEN Nan, XUE Junjie, FENG Lei.
Research progress on lactylation in hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(5): 640-646.
|
| [5] |
ZHAO Wensi, CAO Dedong, ZHAO Nan.
A comparative analysis of efficacy and safety of immune checkpoint inhibitor in combination with chemotherapy versus second⁃line chemotherapy in patients with advanced esophageal squamous cell carcinoma following first⁃line immunotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(4): 432-439.
|
| [6] |
LIU Mengjia, WANG Ke, CHANG Yaxin, MA Huiwen, YANG Zhaoxia.
Longitudinal investigation of symptom clusters in patients with gastrointestinal cancer undergoing radiotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(4): 458-464.
|
| [7] |
QIU Guogao, WANG Jinming, CHEN Shuchang, LIU Shaoping, SU Ze, DONG Xiaofeng, LI Lequn, ZHONG Jianhong, MA Liang, GUIDANCE cooperative group.
ASCO-GI 2025: Research priorities and emerging frontiers in hepatobiliary and pancreatic cancers
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 264-272.
|
| [8] |
SU Jiayong, LIN Leipo, HUANG Zhihao, LI Jianrong, PAN Lixin, MA Liang, LI Lequn, MA Yili, ZHONG Jianhong.
Advancements in the study of tertiary lymphoid structures within solid tumors: A case analysis of hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 273-280.
|
| [9] |
LI Wenyang, SU Jiayong, LIU Shaoping, LIU Zhen, PENG Ning, LUO Min, FAN Yuan, LIN Leipo, MA Liang, LI Lequn, ZHONG Jianhong.
Efficacy of transcatheter arterial chemoembolization following radical resection in cases of intermediate to advanced hepatocellular carcinoma with microvascular invasion: A multicenter cohort study
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 281-288.
|
| [10] |
XU Shaowei, TANG Zhihong, WEI Meng, LIU Danxi, YUAN Du, PANG Qingqing, BAI Tao, CHEN Jie, WANG Xiaobo, LI Lequn, WU Feixiang.
Development and validation of a nomogram model for predicting pathological complete response following conversion therapy for hepatocellular carcinoma based on biological markers and imaging features
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 289-296.
|
| [11] |
NIE Liyun, NONG Qingqing, LI Jiangheng, GUAN Bin, HUANG Yuying, CHEN Yuyun.
Role of GCLC promoter methylation on microcystin?LR?induced hepatocyte malignant transformation and the interventional effects of 5?aza?2′?deoxycytidine
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 297-304.
|
| [12] |
HUANG Zigui, HUANG Xiaoliang, LIU Jungang, MO Xianwei, TANG Weizhong.
Recent advances in the prevention and treatment of colorectal cancer: From precision screening to personalized therapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 305-311.
|
| [13] |
ZENG Guang, LI Fuyue, ZHANG Ruoxin, XU Wanghong, LIU Hongliang, WEI Qingyi.
Research advances in RNA alternative splicing in gastric cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 312-319.
|
| [14] |
CAO Qian, YAN Meng, ZHOU Meng, ZHANG Zhen, ZHU Ji.
Advances in the application of radiomics and artificial intelligence in chemoradiotherapy for locally advanced rectal cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 320-327.
|
| [15] |
LIN Yongtian, MA Jingyu, HE Jing, XIANG Zhisheng, WEN Yeying, FAN Guisheng, LIU Qingyan, CHEN Xuan, LIN Muxing, ZHOU Yan.
Health economic evaluation of upper gastrointestinal cancer screening in Fujian Province based on Markov model
[J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(3): 328-334.
|
